Related Experiment Video

Updated: Jun 27, 2026

Computed Tomography (CT) Guided Implantation of a Totally Implantable Venous Access Port (TIVAP) through Subclavian Vein
05:51

Computed Tomography (CT) Guided Implantation of a Totally Implantable Venous Access Port (TIVAP) through Subclavian Vein

Published on: January 13, 2026

Central venous access ports in children treated for hematopoietic malignancies

Bogusław Bucki1, Renata Tomaszewska, Jacek Karpe

  • 1Department of Emergency Medicine, Bytom, Medical University of Silesia, Katowice, Poland.

Pediatric Hematology and Oncology
|December 10, 2008
PubMed

Insights

Central venous access ports (CVAP) are safe and effective for delivering chemotherapy in pediatric cancer patients. Complications were infrequent, with infection being the most common reason for removal.

Area of Science:

  • Pediatric Oncology
  • Medical Devices
  • Vascular Access

Background:

  • Central venous access ports (CVAP) are crucial for long-term chemotherapy administration in pediatric cancer.
  • Evaluating the safety and efficacy of CVAP implantation is essential for patient care.

Purpose of the Study:

  • To assess the safety and complication rates of subcutaneously implanted central venous access ports (CVAP) in pediatric oncology patients.
  • To determine the effectiveness of CVAP for delivering high-dose chemotherapy.

Main Methods:

  • Retrospective analysis of 234 central venous access ports (CVAP) implanted in 225 pediatric patients over 10 years.
  • Data collection on implantation details, duration of use, and types of complications.

Main Results:

  • A total of 234 CVAPs were implanted, with a mean exposure time of 745 days.
  • Complications occurred in 7.6% of patients, with central venous line infection (4.4%) being the most frequent reason for CVAP removal.
  • Mechanical issues like catheter fracture and occlusion also necessitated removal.

Conclusions:

  • Subcutaneously implanted central venous access ports (CVAP) are a safe and effective method for delivering high-dose chemotherapy in children with cancer.
  • Low complication rates support the continued use of CVAP in this patient population.

More Related Videos

Hickman Catheter Use for Long-Term Vascular Access in a Preclinical Swine Model08:51

Hickman Catheter Use for Long-Term Vascular Access in a Preclinical Swine Model

Published on: March 31, 2023

Related Concept Videos

Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...